Elapegademase (formerly referred to as pegademase bovine) is an enzyme replacement therapy used to treat adenosine deaminase deficiency, an inherited metabolic disorder. It is a modified form of the human adenosine deaminase (ADA) enzyme, and is produced through recombinant DNA technology. Elapegademase is administered as an intravenous infusion, and works by replacing the missing enzyme in the body to help break down toxic compounds and allow for normal development.
Elapegademase is a medication used for a specific condition called adenosine deaminase severe combined immunodeficiency (ADA-SCID) https://www.ncbi.nlm.nih.gov/books/NBK1483/. ADA-SCID is a rare inherited disorder where the body lacks an essential enzyme called adenosine deaminase (ADA). This enzyme deficiency weakens the immune system, making individuals with ADA-SCID highly susceptible to severe and recurrent infections.
Here's a breakdown of Elapegademase:
- Function: Elapegademase acts as an enzyme replacement therapy https://pubmed.ncbi.nlm.nih.gov/34042028/. It's a man-made form of ADA that is administered into the body to compensate for the missing enzyme in ADA-SCID patients. By providing a functional ADA, Elapegademase helps regulate the immune system and reduces the risk of infections.
- Applications: Elapegademase is approved for treatment of ADA-SCID in both children and adults.
- Dosage and form: Elapegademase is delivered through weekly intramuscular injections (shots in the muscle). A healthcare professional will administer the medication.
- Side effects: Generally, Elapegademase is well-tolerated. However, some potential side effects include:
- Injection site reactions (pain, redness, swelling)
- Headache
- Fever
- Muscle aches
Important considerations:
- Elapegademase may interact with other medications, particularly those containing polyethylene glycol (PEG). It's important to disclose your complete medication history to your doctor before starting Elapegademase.
- Pregnant or breastfeeding women should consult with their doctor about the risks and benefits of using Elapegademase.
- Elapegademase is a lifelong treatment for ADA-SCID. Regular monitoring by a healthcare professional is necessary to track treatment response and manage any potential side effects.
In conclusion, Elapegademase is a crucial treatment for ADA-SCID, helping individuals with this rare condition to manage their immune system and live healthier lives. If you have any questions or concerns about ADA-SCID or Elapegademase, consult with a healthcare professional.